InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14- |
SHGAZHPCJJPHSC-XFYACQKRSA-N |
CC(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C\C(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
teratogenic agent
A role played by a chemical compound in biological systems with adverse consequences in embryo developments, leading to birth defects, embryo death or altered development, growth retardation and functional defect.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via retinoic acid )
|
|
keratolytic drug
A drug that softens, separates, and causes desquamation of the cornified epithelium or horny layer of skin. Keratolytic drugs are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
|
isotretinoin
|
ChemIDplus
|
isotretinoína
|
WHO MedNet
|
isotrétinoine
|
WHO MedNet
|
isotretinoinum
|
ChemIDplus
|
(7E,9E,11E,13Z)-retinoic acid
|
JCBN
|
13-cis-retinoic acid
|
JCBN
|
13-cis-Vitamin A acid
|
ChemIDplus
|
13-RA
|
ChemIDplus
|
cis-RA
|
ChEBI
|
isotretinoino
|
ChemIDplus
|
Neovitamin A acid
|
ChemIDplus
|
Accutane
|
DrugBank
|
Amnesteem
|
DrugBank
|
Claravis
|
DrugBank
|
1885770
|
Reaxys Registry Number
|
Reaxys
|
4759-48-2
|
CAS Registry Number
|
ChemIDplus
|
11606947
|
PubMed citation
|
Europe PMC
|
11866680
|
PubMed citation
|
Europe PMC
|
15304471
|
PubMed citation
|
Europe PMC
|
18077132
|
PubMed citation
|
Europe PMC
|
18788179
|
PubMed citation
|
Europe PMC
|
19568610
|
PubMed citation
|
Europe PMC
|
20482692
|
PubMed citation
|
Europe PMC
|
23676507
|
PubMed citation
|
Europe PMC
|
9807973
|
PubMed citation
|
Europe PMC
|
|